Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Net Cash Flow (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Net Cash Flow for 3 consecutive years, with $115.9 million as the latest value for Q1 2026.

  • Quarterly Net Cash Flow rose 613.59% to $115.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $237.0 million through Jan 2026, up 504.02% year-over-year, with the annual reading at $229.3 million for FY2025, 3503.26% up from the prior year.
  • Net Cash Flow for Q1 2026 was $115.9 million at Kestra Medical Technologies, up from -$25.8 million in the prior quarter.
  • The five-year high for Net Cash Flow was $183.2 million in Q2 2025, with the low at -$36.4 million in Q3 2025.
  • Average Net Cash Flow over 3 years is $34.5 million, with a median of -$14.7 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 2766.9% in 2025, while the deepest fall reached 139.67% in 2025.
  • Over 3 years, Net Cash Flow stood at -$23.1 million in 2024, then decreased by 11.88% to -$25.8 million in 2025, then soared by 549.39% to $115.9 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $115.9 million, -$25.8 million, and -$36.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.